| Literature DB >> 13618740 |
Abstract
A new skeletal muscle relaxant, methocarbamol, was used in the treatment of 38 patients with a variety of severe neurological disorders and skeletal muscle spasm states.Eighty-two per cent of the patients studied obtained a beneficial result ranging from excellent to fair. Mild side effects such as drowsiness were observed in five patients, mild weakness in three patients and excessive perspiration in one. In two of the five patients who complained of drowsiness, it disappeared upon reduction of dosage and did not reappear when original dosage was reinstituted.Entities:
Keywords: MUSCLE RELAXANTS/therapeutic use; MUSCLES/diseases; NERVOUS SYSTEM/diseases
Mesh:
Substances:
Year: 1959 PMID: 13618740 PMCID: PMC1577532
Source DB: PubMed Journal: Calif Med ISSN: 0008-1264